Emergency drug use in a pandemic: Harsh lessons from COVID-19.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34587491.
- Also identified by DOI 10.1016/j.cell.2021.09.025 and PMC identifier 8452505.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The scientific and clinical communities have both experienced several harsh lessons on clinical care management and drug development during the COVID-19 pandemic. Here, we discuss several key lessons learned and describe a framework within which our two communities can work together and invest in to improve future pandemic responses.
Medical subject headings
- Drug Development
- Pandemics
- COVID-19 Drug Treatment